• 1
    Jemal A,Siegel R,Ward E,Murray T,Xu J,Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007; 57: 43-66.
  • 2
    Yeo CJ,Cameron JL,Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg. 1995; 221: 721-731; discussion 731-723.
  • 3
    Li D,Xie K,Wolff R,Abbruzzese JL. Pancreatic cancer. Lancet. 2004; 363: 1049-1057.
  • 4
    [No authors listed]Comparative therapeutic trial of radiation with or without chemotherapy in pancreatic carcinoma. Gastrointestinal Tumor Study Group. Int J Radiat Oncol Biol Phys. 1979; 5: 1643-1647.
  • 5
    [No authors listed] Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group. J Natl Cancer Inst. 1988; 80: 751-755.
  • 6
    Willett CG,Czito BG,Bendell JC,Ryan DP. Locally advanced pancreatic cancer. J Clin Oncol. 2005; 23: 4538-4544.
  • 7
    Ceha HM,van Tienhoven G,Gouma DJ, et al. Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma. Cancer. 2000; 89: 2222-2229.
  • 8
    Chang ST,Goodman KA,Yang GP,Koong AC. Stereotactic body radiotherapy for unresectable pancreatic cancer. Front Radiat Ther Oncol. 2007; 40: 386-394.
  • 9
    Koong AC,Christofferson E,Le QT, et al. Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2005; 63: 320-323.
  • 10
    Koong AC,Le QT,Ho A, et al. Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2004; 58: 1017-1021.
  • 11
    Schellenberg D,Goodman KA,Lee F, et al. Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2008; 72: 678-686.
  • 12
    Xing L,Thorndyke B,Schreibmann E, et al. Overview of image-guided radiation therapy. Med Dosim. 2006; 31: 91-112.
  • 13
    Kaplan EL,Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53: 457-481.
  • 14
    Klaassen DJ,MacIntyre JM,Catton GE,Engstrom PF,Moertel CG. Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil–an Eastern Cooperative Oncology Group study. J Clin Oncol. 1985;: 373-378.
  • 15
    Hoyer M,Roed H,Sengelov L, et al. Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. Radiother Oncol. 2005; 76: 48-53.
  • 16
    Guerrero M,Li XA. Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy. Phys Med Biol. 2004; 49: 4825-4835.
  • 17
    Moertel CG,Frytak S,Hahn RG, et al. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: the Gastrointestinal Tumor Study Group. Cancer. 1981; 48: 1705-1710.
  • 18
    Garcia-Barros M,Paris F,Cordon-Cardo C, et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science. 2003; 300: 1155-1159.
  • 19
    Koong AC,Mehta VK,Le QT, et al. Pancreatic tumors show high levels of hypoxia. Int J Radiat Oncol Biol Phys. 2000; 48: 919-922.
  • 20
    Minsky BD,Hilaris B,Fuks Z. The role of radiation therapy in the control of pain from pancreatic carcinoma. J Pain Symptom Manage. 1988; 3: 199-205.